Cargando…
Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report
KEY CLINICAL MESSAGE: Thrombotic microangiopathies are a side effect of anti‐VEGF therapies, which are often limited to the kidneys but can also occur systemically and be life‐threatening. Screening for increasing proteinuria is essential. ABSTRACT: We present the case of a 65‐year‐old male patient...
Autores principales: | Stortz, Marco, Shmanko, Kateryna, Kraus, Daniel, Gairing, Simon, Boedecker‐Lips, Simone, Förster, Friederich, Weinmann, Arndt, Weinmann‐Menke, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636558/ https://www.ncbi.nlm.nih.gov/pubmed/37953891 http://dx.doi.org/10.1002/ccr3.8124 |
Ejemplares similares
-
Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary care centre
por: Schmidtmann, Irene, et al.
Publicado: (2023) -
No Evidence for Classic Thrombotic Microangiopathy in COVID-19
por: Falter, Tanja, et al.
Publicado: (2021) -
Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children
por: Huang, Jun, et al.
Publicado: (2020) -
Plasma exchange in Immunoglobulin A nephropathy with thrombotic microangiopathy and acute cortical necrosis
por: Doddi, P., et al.
Publicado: (2016) -
Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)